What does Alamar Biosciences, Inc. do?
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT)…
What is Alamar Biosciences, Inc.'s P/E and P/B ratio?
Alamar Biosciences, Inc. has a P/E ratio of -24.8 and a P/B ratio of 6.59.
What is Alamar Biosciences, Inc.'s debt-to-equity ratio?
Alamar Biosciences, Inc. has a debt-to-equity ratio of 0.16.
How much does Alamar Biosciences, Inc. owe compared with what it owns?
Alamar Biosciences, Inc. owes $0.20 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Alamar Biosciences, Inc.'s Positivity rank?
Alamar Biosciences, Inc. is ranked #5,356 of 6,774 companies globally and #2,901 of 4,000 in United States on PositoAI, with a Positivity Score of 17,653.
Does Alamar Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Alamar Biosciences, Inc..
Where can I read the latest news about Alamar Biosciences, Inc.?
Recent headlines about Alamar Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Alamar Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Alamar Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.